No abstract available
MeSH terms
-
Anticholesteremic Agents / adverse effects*
-
Anticholesteremic Agents / therapeutic use
-
Apolipoprotein A-I / metabolism
-
Cardiovascular Diseases / chemically induced
-
Cardiovascular Diseases / drug therapy
-
Cardiovascular Diseases / mortality*
-
Cholesterol Ester Transfer Proteins / antagonists & inhibitors*
-
Cholesterol, HDL / blood*
-
Humans
-
Quinolines / adverse effects*
-
Up-Regulation
Substances
-
Anticholesteremic Agents
-
Apolipoprotein A-I
-
Cholesterol Ester Transfer Proteins
-
Cholesterol, HDL
-
Quinolines
-
torcetrapib